Company Name
NeuroFix, S.A.
Activity
Lipid-based therapies for the treatment of neurological pathologies
CIF
A37542834
Sector
Bio
Address
Parque Científico Universidad de Salamanca, M3 PB5 CP37185 Villamayor - Salamanca
EPM Joining Date
23/03/2020
Creation Date
20/03/2015
Investors email contact
info@neurofixpharma.com
Presenting Partner
EpM
Company profile
Neurofix is a biotechnology company founded by experienced scientists and executives. Our pipeline consists of products both at clinical and pre-clinical development stages.
Lipid-based therapies for the treatment of neurological pathologies
On the Road to BME Growth
- 13/10/2020 - Capital Disclosure
- 07/04/2021 - Bylaws modification BME Growth requirements
- 26/10/2020 - Board of Directors
- 12/05/2020 - Transformation in PLC
Relevant data
| (thousand of Euros) | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net worth | 371 | 731 | 1.074,27 | 1.956,08 |
| Net business turnover | 00 | 00 | 00 | 00 |
| Financial debt | 00 | 252 | 469,05 | 552 |
| Ebitda | -51 | 56 | -178,6 | -301,31 |
| Net Profit | -38 | 42 | -199,51 | -15,34 |
| Average number of employees | 02 | 03 | 03 | 03 |
Investment Rounds
| Date | Status | Amount | Minimum Ticket |
|---|---|---|---|
| 12-04-2021 | Closed | 1.500.000 | 1035,00 |
| 18-01-2022 | Closed | 3.500.000 | 264,00 |
| 16-11-2022 | Closed | 7.000.000 | 317,00 |
